Comunicati Stampa
Salute e Benessere

SciBase changes Certified Adviser to Carnegie Investment Bank AB (publ)

For additional information, please contact:Pia Renaudin, VD, tel. +46732069802, e-mail: pia.renaudin@scibase.comCertified Advisor (CA): For additional information, please contact: Pia Renaudin, VD, tel. +46732069802, e-mail:pia.renaudin@scibase.com Certified Advisor (CA): Vator Securities Tel: +46 8 580 065 99 Email:  ca@vatorsec.se About SciBase: SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase...
STOCKHOLM, (informazione.news - comunicati stampa - salute e benessere)


Pia Renaudin, VD , tel. +46732069802, e-mail: pia.renaudin@scibase.com

Vator Securities
Tel: +46 8 580 065 99
Email: ca@vatorsec.se

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden , SciBase is a leader in dermatological advancements.

The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015 . Learn more at www.scibase.com. All press releases and financial reports can be found here: http://investors.scibase.se/en/pressreleases

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/scibase/r/scibase-changes-certified-adviser-to-carnegie-investment-bank-ab--publ-,c4026505

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/scibase-changes-certified-adviser-to-carnegie-investment-bank-ab-publ-302227268.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili